That may be fine with Roche’s patient founding family, which controls the firm thanks to its dual-share structure, but it could dismay other investors.
Don't underestimate the old-fashioned, non-technical controls that have served financial institutions well: separation of duties, forcing employees to take vacations, dual-control systems, etc.